Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ)
CNY 7.84
(0.38%)
CNY 7.84
(0.38%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.92 Billion CNY | -2.14% |
| 2022 | 1.97 Billion CNY | 26.61% |
| 2021 | 1.55 Billion CNY | 4.92% |
| 2020 | 1.48 Billion CNY | 28.32% |
| 2019 | 1.15 Billion CNY | 24.76% |
| 2018 | 926.43 Million CNY | 25.23% |
| 2017 | 739.79 Million CNY | 26.46% |
| 2016 | 585.01 Million CNY | 22.0% |
| 2015 | 479.52 Million CNY | 25.04% |
| 2014 | 383.49 Million CNY | 45.3% |
| 2013 | 263.94 Million CNY | 38.62% |
| 2012 | 190.4 Million CNY | 45.0% |
| 2011 | 131.31 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 486.13 Million CNY | 1.75% |
| 2024 Q2 | 426.81 Million CNY | -12.2% |
| 2024 Q3 | 501.79 Million CNY | 17.57% |
| 2023 Q4 | 477.77 Million CNY | 10.18% |
| 2023 FY | 1.92 Billion CNY | -2.14% |
| 2023 Q1 | 622.9 Million CNY | 18.56% |
| 2023 Q2 | 395.94 Million CNY | -36.44% |
| 2023 Q3 | 433.61 Million CNY | 9.51% |
| 2022 Q4 | 525.38 Million CNY | -10.36% |
| 2022 FY | 1.97 Billion CNY | 26.61% |
| 2022 Q3 | 586.1 Million CNY | 58.16% |
| 2022 Q2 | 370.58 Million CNY | -24.09% |
| 2022 Q1 | 488.19 Million CNY | -1.78% |
| 2021 FY | 1.55 Billion CNY | 4.92% |
| 2021 Q2 | 308.58 Million CNY | -22.03% |
| 2021 Q3 | 354.74 Million CNY | 14.96% |
| 2021 Q1 | 395.77 Million CNY | -11.92% |
| 2021 Q4 | 497.04 Million CNY | 40.12% |
| 2020 Q1 | 366.58 Million CNY | -5.55% |
| 2020 Q3 | 400.51 Million CNY | 50.15% |
| 2020 Q2 | 266.73 Million CNY | -27.24% |
| 2020 FY | 1.48 Billion CNY | 28.32% |
| 2020 Q4 | 449.33 Million CNY | 12.19% |
| 2019 Q3 | 258.66 Million CNY | 28.37% |
| 2019 Q2 | 201.5 Million CNY | -34.48% |
| 2019 Q1 | 307.54 Million CNY | 26.97% |
| 2019 FY | 1.15 Billion CNY | 24.76% |
| 2019 Q4 | 388.12 Million CNY | 50.05% |
| 2018 Q3 | 269.56 Million CNY | 82.77% |
| 2018 FY | 926.43 Million CNY | 25.23% |
| 2018 Q1 | 267.16 Million CNY | 18.32% |
| 2018 Q4 | 242.21 Million CNY | -10.15% |
| 2018 Q2 | 147.49 Million CNY | -44.79% |
| 2017 Q1 | 168.29 Million CNY | -0.4% |
| 2017 FY | 739.79 Million CNY | 26.46% |
| 2017 Q3 | 194.24 Million CNY | 28.25% |
| 2017 Q4 | 225.79 Million CNY | 16.24% |
| 2017 Q2 | 151.45 Million CNY | -10.01% |
| 2016 Q3 | 150.76 Million CNY | 82.52% |
| 2016 FY | 585.01 Million CNY | 22.0% |
| 2016 Q4 | 168.97 Million CNY | 12.08% |
| 2016 Q2 | 82.59 Million CNY | -54.78% |
| 2016 Q1 | 182.67 Million CNY | 14.81% |
| 2015 Q2 | 75.98 Million CNY | -41.32% |
| 2015 Q1 | 129.49 Million CNY | 4.96% |
| 2015 FY | 479.52 Million CNY | 25.04% |
| 2015 Q4 | 159.1 Million CNY | 38.44% |
| 2015 Q3 | 114.92 Million CNY | 51.25% |
| 2014 FY | 383.49 Million CNY | 45.3% |
| 2014 Q3 | 96.56 Million CNY | 96.01% |
| 2014 Q1 | 114.29 Million CNY | 0.0% |
| 2014 Q4 | 123.37 Million CNY | 27.76% |
| 2014 Q2 | 49.26 Million CNY | -56.89% |
| 2013 FY | 263.94 Million CNY | 38.62% |
| 2012 FY | 190.4 Million CNY | 45.0% |
| 2011 FY | 131.31 Million CNY | 0.0% |